Results 81 to 90 of about 843,336 (254)

High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris

BMC Cardiovascular Disorders, 2019
Background In-stent restenosis remains an unresolved issue. Inflammation plays a pivotal role in the process of in-stent restenosis. Significant and positive associations were found between red blood cell distribution width (RDW) and inflammation.
Ning Geng, Guangsheng Su, Shaojun Wang, Deling Zou, Wenyue Pang, Yingxian Sun   +5 more
doaj   +1 more source

Coronary Spasm Due to Pulsed Field Ablation: A State‐of‐the‐Art Review

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT With the ever‐growing population of patients undergoing cardiac ablation with pulsed electric fields, there is a need to understand secondary effects from the therapy. Coronary artery spasm is one such effect that has recently emerged as the subject of further investigation in electrophysiology literature.
David A. Ramirez, Kara Garrott, Ann Garlitski, Brendan Koop   +3 more
wiley   +1 more source

Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study

Clinical Cardiology, Volume 48, Issue 8, August 2025.
The effectiveness of percutaneous coronary interventions following a decision tree proposing a stent‐less strategy in stable patients with coronary artery disease is illustrated by Kaplan‐Meier curves of target lesion revascularisation, the study endpoint. DCB: Drug Coated Balloon; DES: Drug Eluting Stent; SCBA: scoring balloon angioplasty.
Ludovic Meunier, Simon Eccleshall, Ronan Bakdi, Matthieu Godin, Géraud Souteyrand, Benoît Mottin, Yann Valy, Christian Benoit, Vincent Lordet, Virginie Laurençon, Antoine Milhem, Matthias Waliszewski, Caroline Allix‐Béguec   +12 more
wiley   +1 more source

Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 2, August 2025.
ABSTRACT Classifications of drug interaction alerts regarding clopidogrel and a proton pump inhibitor (PPI) differ between knowledge resources. In this systematic review, Medline, Embase, and the Cochrane Library were searched for randomized controlled trials (RCTs) applying PICO criteria: P = patients on clopidogrel; I = intervention: PPI (subgroup ...
Magnus A. B. Axelsson, Naldy Parodi López, Eva Wikström Jonsson, Susanna M. Wallerstedt   +3 more
wiley   +1 more source

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.

European Heart Journal, 2008
AIMS The objective of this study was to assess the non-inferiority, in terms of anti-restenotic efficacy, of both biodegradable-polymer (BP) and polymer-free (PF) stents compared with permanent-polymer rapamycin-eluting (PP; Cypher) stent.
J. Mehilli, R. Byrne, A. Wieczorek, R. Iijima, S. Schulz, Olga Bruskina, J. Pache, R. Wessely, A. Schömig, A. Kastrati   +9 more
semanticscholar   +1 more source

Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration—A Comprehensive Review

The FASEB Journal, Volume 39, Issue 14, 31 July 2025.
A graphical summary illustrating the development of bioscaffolds incorporated with miRNA‐loaded lipid nanoparticles. MicroRNA‐encapsulated lipid nanoparticles are blended into a polymer solution, which is then used to fabricate a nanofibrous scaffold through electrospinning.
Jekhan Andimadam Madana Saravanan, Azam Ali, Rajesh Katare   +2 more
wiley   +1 more source

Clinical and angiographic assessment of coronary bare-metal stent restenosis

CorSalud, 2017
Introduction: Ischemic heart disease is the leading cause of death in Cuba. Coronary angioplasty with stenting is an excellent treatment option, but restenosis overshadows its prognosis and is more common with the use of bare metal stents.
Max G. Sánchez Manzanares, Francisco L. Moreno-Martínez, Iguer F. Aladro Miranda, Luis F. Vega Fleites, Rosendo S. Ibargollín Hernández, José R. Nodarse Valdivia, Norge R. Lara Pérez, Alejandro Agüero Sánchez, Reinaldo C. Gavilanes García, Lill D. Vega Plá, Leonardo Pérez González, Maribel I. Noda Valledor, Ricardo Oroz Moreno, Wanda Báez La Rosa   +13 more
doaj  

To Investigate the Clinical Efficacy and Potential Mechanism of Tongxinluo Capsules in Preventing Coronary Restenosis Based on Meta-Analysis and Network Pharmacology Analysis. [PDF]

Evid Based Complement Alternat Med, 2023
Wei WX, Jiang YH.
europepmc   +1 more source

Risk factors for instent restenosis of sirolimus-coated stents in coronary intervention for patients with unstable angina

Scientific Reports
To investigate the instent restenosis rate of sirolimus-coated stents in percutaneous coronary intervention (PCI) and risk factors for in-stent restenosis, patients with unstable angina (UA) caused by coronary artery stenosis were enrolled, and all ...
Dongchao Liu, Zheng Xue, Jingxian Qi, Liang Yin, Bing Duan, Lin Wu, Kun Yang, Bulang Gao, Qinying Cao, Jie Mi   +9 more
doaj   +1 more source

Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model. [PDF]

J Korean Med Sci, 2021
Cho KH, Jeong MH, Park DS, Kim M, Kim J, Park JK, Han X, Hyun DY, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y.   +12 more
europepmc   +1 more source